HOUSTON, May 29, 2025 /PRNewswire/ -- Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today ...
Immunotherapy. 2012;4:1063-1074. DCs transduced with IL-4 vectors 105,106 DCs transduced with IL-10 vectors 107–109 DCs transduced with viral IL-10 vectors 110 DCs transduced with CTLA4–Ig vectors 104 ...
Treating the brain cancer glioblastoma (GBM) demands more than conventional strategies due to a mix of factors including the cancer’s genetic complexity, invasive growth, and immune resistance. A new ...
Landmark preclinical data validate Renovaro's platform representing a step forward in the fight against pancreatic and solid tumors LOS ANGELES, CALIFORNIA / ACCESS Newswire / July 17, 2025 / Renovaro ...
Cancer immunotherapy has advanced the field of medicine and cancer care. Specifically, immunotherapy refers to the targeted treatment of the immune system. Over the last few decades, immunotherapy has ...
The FDA has granted breakthrough therapy designation for litifilimab in patients with cutaneous lupus erythematosus, ...
To understand the University of Florida’s nanoparticle imaging research and its potential to boost cancer immunity, think of bloodhounds sniffing out troubled targets. White blood cells (T cells) are ...
1 Department of Pathology, University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, Rangos Research Center, 4401 Penn Avenue, Pittsburgh, PA 15224, USA 2 Department of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results